• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 WITH SHUNTASSISTANT 20; HYDROCEPHALUS VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 WITH SHUNTASSISTANT 20; HYDROCEPHALUS VALVES Back to Search Results
Model Number FX413T
Device Problems Mechanical Jam (2983); Overcorrection (3006)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Manufacturing site evaluation: evaluation on-going.Date of event: unknown.Date of implant: unknown.Pending further information.
 
Event Description
It was reported by the healthcare professional to the company sales representative "valve unadjustable was implanted, operated on to remove and customer stated valve is jammed.".
 
Manufacturer Narrative
Investigation: visual inspection: scratches and bloody residue on the outer housing of the valve was observed through the visual inspection.No significant deformations or damages were detected.Permeability test: a permeability test has shown that the progav 2.0 valve is permeable.Adjustment test: the progav 2.0 valve was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Results: we have dismantled the valve.We found deposits of substances (likely protein) both inside the valve and on the inside of the top of the valve.Based on our investigation, we are unable to substantiate the claim of non-adjustability.The valve operates within the specified tolerances.However, it is possible that the deposits observed inside the valve could have caused the malfunction in the past.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 WITH SHUNTASSISTANT 20
Type of Device
HYDROCEPHALUS VALVES
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam, D-144 69
GM  D-14469
MDR Report Key7834439
MDR Text Key118813021
Report Number3004721439-2018-00210
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K141687
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2021
Device Model NumberFX413T
Device Catalogue NumberFX413T
Device Lot Number20031602
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/24/2018
Distributor Facility Aware Date11/09/2018
Device Age2 YR
Initial Date Manufacturer Received 06/28/2018
Initial Date FDA Received08/30/2018
Supplement Dates Manufacturer Received11/09/2018
Supplement Dates FDA Received12/04/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age2 YR
-
-